Percuros is currently co-ordinating a European Union Marie Curie IAPP project, BRAINPATH, to build upon current developments in molecular imaging. The consortium will create an academic-industrial training and mobility network for the next revolution of imaging technology for the brain. The other partners in the consortium are Max Planck Institute for Neurological Research, Leiden University Medical Center, icoMetrix N.V., University of Antwerp, Technical University of Munich, FOM-AMOLF (Institute for Atomic and Molecular Physics and Medres GmbH.
Percuros was recently awarded, as co-ordinator, a European Commission MSCA-ITN-2015-ETN Action grant to investigate the use of nanoparticles for combination immunotherapy. This work will be performed in conjunction with a number of European partners both for academia and industry. Nineteen early stage researchers have been recruited across the partner sites where the project will start at the end of this year. For more infomation: www.ispic.eu
On January 18 and 19 2018, TargetCaRe ESRs, PIs and partners organizations
representatives met in Haifa for the sixth consortium meeting. The meeting was hosted by
Technion and organized with the support of Technion and Procore. ESRs presented their
progresses. Scientific discussions and mentoring sessions took place as well. The project
entered in its last year, it will be a very challenging time! In addition, the fascinating
location of Haifa, in Israel, gave to the consortium members the opportunity to know more
about local history and culture.
www.targetcare.eu/targetcare-consortium- meeting-in- haifa/
The Province of South Holland has awarded a subsidy of €200,000 to a joint project
between SeraNovo and Percuros, with consultancy from Good Biomarker Sciences. The
project allows SeraNovo to further develop their technology platform, while testing it on
the advanced test Percuros will develop. SeraNovo’s technology allows new medicines to
be absorbed in the human body that previously could not.
CANCER project started in March in Nemi within the H2020 RISE programme 2017. The
consortium of universities, SMEs and associations gathered for the kick-off meeting last 9 th
and 10 th April in the wonderful location of Ruspoli Castel in Nemi to discuss about their
future plans of action. Our aim is to study new immunotherapy approaches to improving
cancer outcome and quality of life (QOL). Follow all our progresses on the project website
or on our Facebook page.
Percuros has been awarded three more grants and will launch three projects:
- PREPARED – A EUROSTARS funded project together with two organisations from Denmark, Atonomics and The Parker Institute (Copenhagen University Hospital), both based in Copenhagen. The program will allow the development of new point-of-care assays for therapeutic monitoring of rheumatoid arthritis.
- CANCER – A European H2020 MSCA RISE grant to study how the new cancer immunotherapy checkpoint blockers affect patients in terms of their quality of life and the impact of such treatment on their long term immune status.
- ARCATOR - A three-year project funded by EUROSTARS together with SIMFO GmbH, based in Bayreuth (Germany) to work on mid-throughput assays for measuring circulating tumour cells in liquid biopsies.